 WON-SALEM, N.C., Sept. 08, 2022 GLOBE NEWSWIRE -- ProKidney Corp. Nasdaq: PROK ProKidney, a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease CKD, today announced that Dr. Tim Bertram, Chief Executive Officer of ProKidney, will participate in a fireside chat on Wednesday, September 14, 2022, at the Morgan Stanley 20 th Annual Global Healthcare Conference, in New York, NY. During the fireside chat, ProKidney plans to discuss its commercialization strategies and potential line extensions to expand market access, approaches to drive down cost of goods, and scaling of manufacturing to meet future market demand. 